Seven Bridges

Velsera Makes NVIDIA Parabricks Tools Available for Global Researchers on the Seven Bridges Platform

Retrieved on: 
Thursday, November 2, 2023

Velsera, a global healthcare technology company offering a universal software platform to connect clinical care with discovery, is collaborating with NVIDIA to bring the NVIDIA Parabricks software suite to its Seven Bridges Platform.

Key Points: 
  • Velsera, a global healthcare technology company offering a universal software platform to connect clinical care with discovery, is collaborating with NVIDIA to bring the NVIDIA Parabricks software suite to its Seven Bridges Platform.
  • The Parabricks tools are integrated into the Velsera bioinformatics platform through the Seven Bridges Public Apps Gallery .
  • With its integration, 16,000+ researchers around the world who collaborate through the Seven Bridges Platform can now access NVIDIA’s AI expertise and healthcare computing platforms.
  • The availability of Parabricks on Seven Bridges supports Velsera’s mission to expand access to genomic sequencing analysis and foster innovation.

Tivly Announces David Ramos as New Chief Technology Officer

Retrieved on: 
Tuesday, February 14, 2023

Tivly is pleased to announce the appointment of David Ramos as Chief Technology Officer.

Key Points: 
  • Tivly is pleased to announce the appointment of David Ramos as Chief Technology Officer.
  • In his role as CTO, David will be responsible for leading the development and implementation of Tivly's technology strategy.
  • "We are thrilled to welcome David to the Tivly team," said Mark McClure, CEO of Tivly.
  • "I am excited to join the Tivly team and help drive the company's technology strategy forward," said Ramos.

New Company, Velsera, Represents Summa Equity's Vision to Improve Global Health Outcomes

Retrieved on: 
Thursday, January 12, 2023

The vision for Velsera is supported by thematic-focused impact fund Summa Equity (“Summa”).

Key Points: 
  • The vision for Velsera is supported by thematic-focused impact fund Summa Equity (“Summa”).
  • The promise of precision medicine is held back by barriers across routine health practice and discovery.
  • Velsera sets out to amplify the impact of clinicians, researchers and scientists for the benefit of patients around the world.
  • Velsera unites these companies to advance and bring together their missions which are centered around improving health globally through multi-omics and insights.

Seven Bridges Announces Research Demonstrating the Advantages of Tailored Pangenome References

Retrieved on: 
Thursday, August 4, 2022

BOSTON, Aug. 4, 2022 /PRNewswire/ -- Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced the publication of a study in Nature Communications that details breakthroughs in the application of graph-based approaches to enable development and application of tailored pangenome references.

Key Points: 
  • BOSTON, Aug. 4, 2022 /PRNewswire/ -- Seven Bridges , the industry-leading bioinformatics ecosystem provider, today announced the publication of a study in Nature Communications that details breakthroughs in the application of graph-based approaches to enable development and application of tailored pangenome references.
  • The authors applied this approach to analyze populations of African ancestry from the 1000 Genomes dataset using a tailored pangenome reference.
  • This approach allowed detection of greater than 6 fold more unique variants than were detected using a linear reference genome.
  • Using Seven Bridges' GRAF Suite , the authors analyzed the efficacy of using a tailored pangenome reference compared to joint variant calling.

Seven Bridges Collaborates With University Of São Paulo And Google Cloud To Build A Brazilian Reference Genome

Retrieved on: 
Tuesday, April 19, 2022

BOSTON, April 19, 2022 /PRNewswire/ -- Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced it is collaborating with the University of São Paulo (USP) and Google Cloud, as well as the Associação Genomas Brasil (Brazil Genome Association), to assist the DNA do Brasil (DNABr) project in building a reference genome that represents the genetic diversity of the Brazilian population. Currently, the human reference genome is based primarily on sequencing data acquired from people of European ancestry, making it challenging to identify and treat diseases in the Brazilian population, whose genome is an admixture of Native Americans, Europeans and sub-Saharan Africans. DNABr will use the Seven Bridges GRAF™ Suite to construct an accurate and representative genome graph reference to identify the genetic variations across this heterogeneous and admixed population. Google Cloud will provide significant computational and storage resources to process the vast amounts of whole genome sequencing data needed to build this ancestry-aware reference.

Key Points: 
  • DNABr will use the Seven Bridges GRAF Suiteto construct an accurate and representative genome graph reference to identifythe genetic variations across this heterogeneous and admixed population.
  • Google Cloud will provide significant computational and storage resources to process the vast amounts of whole genome sequencing data needed to build this ancestry-aware reference.
  • To date, the first batch of 3,000 genomes have been processed and stored using Google Cloud.
  • "With our collective expertise in computational, bioinformatic and genomic sciences, Seven Bridges, along with USP and Google Cloud, aim to advance unbiased precision medicine by overcoming scalability and accuracy challenges that plague current approaches,"saidWilliam Moss, CEO, Seven Bridges.

Seven Bridges Expands Platform to Support Execution of Nextflow and WDL Workflows

Retrieved on: 
Thursday, March 10, 2022

BOSTON, March 10, 2022 /PRNewswire/ -- Seven Bridges , the industry-leading bioinformatics ecosystem provider, today announced the expansion of its platform to enable execution of workflows written in Nextflow and Workflow Description Language (WDL).

Key Points: 
  • BOSTON, March 10, 2022 /PRNewswire/ -- Seven Bridges , the industry-leading bioinformatics ecosystem provider, today announced the expansion of its platform to enable execution of workflows written in Nextflow and Workflow Description Language (WDL).
  • In addition, the Seven Bridges platform will continue to support Common Workflow Language (CWL).
  • "By supporting multiple workflow languages, Seven Bridges makes it easier for researchers to realize the benefit of reproducible analysis at scale."
  • In addition to the more than 600 optimized CWL workflows available from Seven Bridges, this release enables researchers to leverage large content repositories of WDL and Nextflow workflows, in addition to workflows developed in-house, on the Seven Bridges platform.

TEGNA Stations to Debut “A Different Cry” Investigation Into Rising Suicide Rates Among Black Youth in America

Retrieved on: 
Thursday, January 20, 2022

TEGNA Inc. (NYSE: TGNA) today announced A Different Cry , a three-part investigation into the rising suicide rates among Black youth in America, will make its digital premiere on TEGNA stations Fire TV and Roku apps and the Watch section of all stations websites beginning Sunday, Jan. 23.

Key Points: 
  • TEGNA Inc. (NYSE: TGNA) today announced A Different Cry , a three-part investigation into the rising suicide rates among Black youth in America, will make its digital premiere on TEGNA stations Fire TV and Roku apps and the Watch section of all stations websites beginning Sunday, Jan. 23.
  • A Different Cry also sheds light on how poor records and data are obscuring the true nature of this crisis in America.
  • Suicide attempts among Black children are double than those of their white peers, said Monika Diaz, content director at TEGNA.
  • A Different Cry consists of three episodes:
    Episode one: Suicide rates among Black children in America are double that of their white peers.

Seven Bridges Unlocks Population-Scale Clinico-Genomic Data for Accelerated Drug Discovery With Commercial Launch of ARIA™

Retrieved on: 
Thursday, October 21, 2021

Since the initial announcement of ARIA in February 2020, Seven Bridges has partnered with research institutes and commercial agencies, using ARIA to drive insights from data at the million-participants scale and above.

Key Points: 
  • Since the initial announcement of ARIA in February 2020, Seven Bridges has partnered with research institutes and commercial agencies, using ARIA to drive insights from data at the million-participants scale and above.
  • Today, Seven Bridges is pleased to offer ARIA for biopharmaceutical and clinical researchers to improve and accelerate discovery of outcomes using clinical and genomics data at population scale.
  • Across the world, numerous initiatives are currently underway to collect massive repositories of genomic and phenotypic data.
  • Seven Bridges enables researchers to extract meaningful insights from genomic and phenotypic data in order to advance precision medicine.

Seven Bridges and Scripps Research Selected to Develop Data Ecosystem for the National Institute of Allergy and Infectious Diseases

Retrieved on: 
Thursday, September 9, 2021

BOSTON, Sept. 9, 2021 /PRNewswire/ -- Seven Bridges , the industry-leading bioinformatics ecosystem provider, and Scripps Research have been awarded a $7.5M contract to develop a federated data ecosystem for the National Institute of Allergy and Infectious Diseases (NIAID) under a project titled the NIAID Data Ecosystem (NDE).

Key Points: 
  • BOSTON, Sept. 9, 2021 /PRNewswire/ -- Seven Bridges , the industry-leading bioinformatics ecosystem provider, and Scripps Research have been awarded a $7.5M contract to develop a federated data ecosystem for the National Institute of Allergy and Infectious Diseases (NIAID) under a project titled the NIAID Data Ecosystem (NDE).
  • "It is a great privilege for Seven Bridges and Scripps Research to be selected to develop the NIAID Data Ecosystem, a selection that respects our organizations' deep expertise and recognizes the long history of collaboration between Seven Bridges and the National Institutes of Health."
  • "The Seven Bridges and Scripps teams have developed extensive infrastructure to support data findability and data analysis, and we have a long history of collaborating with NIAID researchers to share, visualize, and analyze infectious disease data."
  • As part of the NDE, Seven Bridges and Scripps Research will develop an ecosystem that will enable the researchers to discover public and restricted datasets and perform analyses.

Seven Bridges Names David J. Ramos Chief Technology Officer

Retrieved on: 
Tuesday, August 24, 2021

BOSTON, Aug. 24, 2021 /PRNewswire/ -- Seven Bridges , the industry-leading bioinformatics ecosystem provider, today announced the hire of David J. Ramos to fill the role of Chief Technology Officer.

Key Points: 
  • BOSTON, Aug. 24, 2021 /PRNewswire/ -- Seven Bridges , the industry-leading bioinformatics ecosystem provider, today announced the hire of David J. Ramos to fill the role of Chief Technology Officer.
  • He comes to Seven Bridges from CVS Health, where he led the engineering of the company's HealthCloud platform.
  • I look forward to bringing my experience and leadership to Seven Bridges and embrace the opportunity to mentor, inspire and grow this group of talented and diverse teams," said David Ramos, CTO at Seven Bridges.
  • Seven Bridges enables researchers to extract meaningful insights from genomic and phenotypic data in order to advance precision medicine.